Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 May;56(5):792-808.
doi: 10.1038/s41588-024-01707-9. Epub 2024 Apr 18.

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

Caroline M Nievergelt #  1   2   3 Adam X Maihofer #  4   5   6 Elizabeth G Atkinson  7 Chia-Yen Chen  8 Karmel W Choi  9   10 Jonathan R I Coleman  11   12 Nikolaos P Daskalakis  13   14   15 Laramie E Duncan  16 Renato Polimanti  17   18 Cindy Aaronson  19 Ananda B Amstadter  20 Soren B Andersen  21 Ole A Andreassen  22   23 Paul A Arbisi  24   25 Allison E Ashley-Koch  26 S Bryn Austin  27   28   29 Esmina Avdibegoviç  30 Dragan Babić  31 Silviu-Alin Bacanu  32 Dewleen G Baker  4   5   33 Anthony Batzler  34 Jean C Beckham  35   36   37 Sintia Belangero  38   39 Corina Benjet  40 Carisa Bergner  41 Linda M Bierer  42 Joanna M Biernacka  34   43 Laura J Bierut  44 Jonathan I Bisson  45 Marco P Boks  46 Elizabeth A Bolger  14   47 Amber Brandolino  48 Gerome Breen  12   49 Rodrigo Affonseca Bressan  39   50 Richard A Bryant  51 Angela C Bustamante  52 Jonas Bybjerg-Grauholm  53   54 Marie Bækvad-Hansen  53   54 Anders D Børglum  54   55   56 Sigrid Børte  57   58 Leah Cahn  19 Joseph R Calabrese  59   60 Jose Miguel Caldas-de-Almeida  61 Chris Chatzinakos  13   14   62 Sheraz Cheema  63 Sean A P Clouston  64   65 Lucía Colodro-Conde  66 Brandon J Coombes  34 Carlos S Cruz-Fuentes  67 Anders M Dale  68 Shareefa Dalvie  69 Lea K Davis  70 Jürgen Deckert  71 Douglas L Delahanty  72 Michelle F Dennis  35   36   37 Frank Desarnaud  19 Christopher P DiPietro  13   62 Seth G Disner  73   74 Anna R Docherty  75   76 Katharina Domschke  77   78 Grete Dyb  23   79 Alma Džubur Kulenović  80 Howard J Edenberg  81   82 Alexandra Evans  45 Chiara Fabbri  12   83 Negar Fani  84 Lindsay A Farrer  85   86   87   88   89 Adriana Feder  19 Norah C Feeny  90 Janine D Flory  19 David Forbes  91 Carol E Franz  4 Sandro Galea  92 Melanie E Garrett  26 Bizu Gelaye  9 Joel Gelernter  93   94 Elbert Geuze  95   96 Charles F Gillespie  84 Slavina B Goleva  70   97 Scott D Gordon  66 Aferdita Goçi  98 Lana Ruvolo Grasser  99 Camila Guindalini  100 Magali Haas  101 Saskia Hagenaars  11   12 Michael A Hauser  35 Andrew C Heath  102 Sian M J Hemmings  103   104 Victor Hesselbrock  105 Ian B Hickie  106 Kelleigh Hogan  4   5   6 David Michael Hougaard  53   54 Hailiang Huang  13   107 Laura M Huckins  108 Kristian Hveem  57 Miro Jakovljević  109 Arash Javanbakht  99 Gregory D Jenkins  34 Jessica Johnson  110 Ian Jones  111 Tanja Jovanovic  84 Karen-Inge Karstoft  21   112 Milissa L Kaufman  14   47 James L Kennedy  113   114   115   116 Ronald C Kessler  117 Alaptagin Khan  14   47 Nathan A Kimbrel  35   37   118 Anthony P King  119 Nastassja Koen  120 Roman Kotov  121 Henry R Kranzler  122   123 Kristi Krebs  124 William S Kremen  4 Pei-Fen Kuan  125 Bruce R Lawford  126 Lauren A M Lebois  14   15 Kelli Lehto  124 Daniel F Levey  17   18 Catrin Lewis  45 Israel Liberzon  127 Sarah D Linnstaedt  128 Mark W Logue  88   129   130 Adriana Lori  84 Yi Lu  131 Benjamin J Luft  132 Michelle K Lupton  66 Jurjen J Luykx  96   133 Iouri Makotkine  19 Jessica L Maples-Keller  84 Shelby Marchese  134 Charles Marmar  135 Nicholas G Martin  136 Gabriela A Martínez-Levy  67 Kerrie McAloney  66 Alexander McFarlane  137 Katie A McLaughlin  138 Samuel A McLean  128   139 Sarah E Medland  66 Divya Mehta  126   140 Jacquelyn Meyers  141 Vasiliki Michopoulos  84 Elizabeth A Mikita  4   5   6 Lili Milani  124 William Milberg  142 Mark W Miller  129   130 Rajendra A Morey  143 Charles Phillip Morris  126 Ole Mors  54   144 Preben Bo Mortensen  54   55   145   146 Mary S Mufford  69 Elliot C Nelson  44 Merete Nordentoft  54   147 Sonya B Norman  4   5   148 Nicole R Nugent  149   150   151 Meaghan O'Donnell  152 Holly K Orcutt  153 Pedro M Pan  154 Matthew S Panizzon  4 Gita A Pathak  17   18 Edward S Peters  155 Alan L Peterson  156   157 Matthew Peverill  158 Robert H Pietrzak  18   159 Melissa A Polusny  24   74   160 Bernice Porjesz  141 Abigail Powers  84 Xue-Jun Qin  26 Andrew Ratanatharathorn  9   161 Victoria B Risbrough  4   5   6 Andrea L Roberts  162 Alex O Rothbaum  163   164 Barbara O Rothbaum  84 Peter Roy-Byrne  165 Kenneth J Ruggiero  166 Ariane Rung  167 Heiko Runz  168 Bart P F Rutten  169 Stacey Saenz de Viteri  170 Giovanni Abrahão Salum  171   172 Laura Sampson  9   89 Sixto E Sanchez  173 Marcos Santoro  174 Carina Seah  134 Soraya Seedat  103   175 Julia S Seng  176   177   178   179 Andrey Shabalin  76 Christina M Sheerin  20 Derrick Silove  180 Alicia K Smith  84   181 Jordan W Smoller  10   13   182 Scott R Sponheim  24   183 Dan J Stein  120 Synne Stensland  58   79 Jennifer S Stevens  84 Jennifer A Sumner  184 Martin H Teicher  14   185 Wesley K Thompson  186   187 Arun K Tiwari  113   114   115 Edward Trapido  167 Monica Uddin  188 Robert J Ursano  189 Unnur Valdimarsdóttir  190   191 Miranda Van Hooff  192 Eric Vermetten  193   194   195 Christiaan H Vinkers  196   197   198 Joanne Voisey  126   140 Yunpeng Wang  199 Zhewu Wang  200   201 Monika Waszczuk  202 Heike Weber  71 Frank R Wendt  203 Thomas Werge  54   204   205   206 Michelle A Williams  9 Douglas E Williamson  35   36 Bendik S Winsvold  57   58   207 Sherry Winternitz  14   47 Christiane Wolf  71 Erika J Wolf  130   208 Yan Xia  13   107 Ying Xiong  131 Rachel Yehuda  19   209 Keith A Young  210   211 Ross McD Young  212   213 Clement C Zai  13   113   114   115   116   214 Gwyneth C Zai  113   114   115   116   215 Mark Zervas  101 Hongyu Zhao  216 Lori A Zoellner  158 John-Anker Zwart  23   57   58 Terri deRoon-Cassini  48 Sanne J H van Rooij  84 Leigh L van den Heuvel  103   104 AURORA StudyEstonian Biobank Research TeamFinnGen InvestigatorsHUNT All-In PsychiatryMurray B Stein  4   33   217 Kerry J Ressler  14   47   84 Karestan C Koenen  9   13   182
Affiliations
Meta-Analysis

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

Caroline M Nievergelt et al. Nat Genet. 2024 May.

Abstract

Post-traumatic stress disorder (PTSD) genetics are characterized by lower discoverability than most other psychiatric disorders. The contribution to biological understanding from previous genetic studies has thus been limited. We performed a multi-ancestry meta-analysis of genome-wide association studies across 1,222,882 individuals of European ancestry (137,136 cases) and 58,051 admixed individuals with African and Native American ancestry (13,624 cases). We identified 95 genome-wide significant loci (80 new). Convergent multi-omic approaches identified 43 potential causal genes, broadly classified as neurotransmitter and ion channel synaptic modulators (for example, GRIA1, GRM8 and CACNA1E), developmental, axon guidance and transcription factors (for example, FOXP2, EFNA5 and DCC), synaptic structure and function genes (for example, PCLO, NCAM1 and PDE4B) and endocrine or immune regulators (for example, ESR1, TRAF3 and TANK). Additional top genes influence stress, immune, fear and threat-related processes, previously hypothesized to underlie PTSD neurobiology. These findings strengthen our understanding of neurobiological systems relevant to PTSD pathophysiology, while also opening new areas for investigation.

PubMed Disclaimer

Conflict of interest statement

L.J.B. is listed as an inventor on Issued U.S. Patent 8,080,371, “Markers for Addiction” covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. C.-Y.C. and H.R. are employees of Biogen. A.M.D. holds equity in CorTechs Labs, Inc., and serves on the Scientific Advisory Board of Human Longevity, Inc., and the Mohn Medical Imaging and Visualization Centre; A.M.D. receives funding through research grants with General Electric Healthcare. C.F. was a speaker for Janssen in 2021. I.B.H. is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney; the BMC operates an early-intervention youth services at Camperdown under contract to headspace. I.B.H. is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd; InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30 M Australian Government-funded Project Synergy. H.H. received consultancy fees from Ono Pharmaceutical and honorarium from Xian Janssen Pharmaceutical. In the past 3 years, R.C.K. was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc., and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM, Roga Sciences and Verisense Health. L.A.M.L. reports spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. C.M. has served on advisory boards of Receptor Life Sciences, Otsuka Pharmaceuticals and Roche Products Limited and has received support from National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, Department of Defense- CDMRP * US Army Research Office * DARPA, Bank of America Foundation, Brockman Foundation, Cohen Veterans Bioscience, Cohen Veterans Network, McCormick Foundation, Home Depot Foundation, New York City Council, New York State Health, Mother Cabrini Foundation, Tilray Pharmaceuticals, and Ananda Scientific. P.M.P. received payment or honoraria for lectures and presentations in educational events for Sandoz, Daiichi Sankyo, Eurofarma, Abbot, Libbs, Instituto Israelita de Pesquisa e Ensino Albert Einstein, Instituto D’Or de Pesquisa e Ensino. R.P. has been paid for his editorial work on the journal Complex Psychiatry and received a research grant outside the scope of this study from Alkermes. J.W.S. is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received grant support from Biogen, Inc.; J.W.S. is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. M.B.S. has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Biogen, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sage Therapeutics, Sumitomo Pharma, and Roche/Genentech. M.B.S. has stock options in Oxeia Biopharmaceuticals and EpiVario. M.B.S. has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). M.B.S. has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. M.B.S. is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. In the past 3 years, D.J.S. has received consultancy honoraria from Discovery Vitality, Johnson & Johnson, Kanna, L’Oreal, Lundbeck, Orion, Sanofi, Servier, Takeda and Vistagen. M.L.K. reports unpaid membership on the Scientific Committee for the ISSTD. All other authors declare no competing interests.

Figures

Extended data Figure 1:
Extended data Figure 1:. Comparison of the genetic architecture of PTSD in the three main data sources.
Quantification of polygenicity and polygenic overlap in the three main data subsets based on (1) symptom scores in clinical studies and cohorts assessed on a variety of instruments in Freeze 2.5 (yellow; 26,080 cases and 192,966 controls), (2) PCL (for DSM-IV) based symptom scores in the MVP (red; 32,372 cases and 154,317 controls), and (3) ICD9/10 codes in EHR studies (blue; 78,684 cases and 738,463 controls) indicate a similar genetic architecture. The circles on the top half of the plot depict univariate MiXeR estimates of the total polygenicity for each data subset. Numbers within circles indicate polygenicity values, expressed as the number of variants (in thousands, with SE in parenthesis) necessary to explain 90% of SNP based heritability (h2SNP). h2SNP estimates are written in the boxes at the bottom of the circles. The Euler diagrams on the bottom half of the plot depict bivariate MiXeR estimates of the polygenic overlap between data subsets. Values in the overlapping part of the Euler diagrams denote shared polygenicity and values on the non-overlapping parts note dataset-specific polygenicity. Genetic correlations (rg) between dataset pairs are noted in the boxes below the Euler diagrams. Arrowed lines are drawn between univariate and bivariate results to indicate which dataset pairs are being evaluated. Abbreviations: Neff, effective sample size.
Extended data Figure 2:
Extended data Figure 2:. Manhattan plot of the PTSD GWAS meta-analysis in individuals of European ancestry (EA).
Results of the EA GWAS meta-analysis (137,136 PTSD cases, 1,085,746 controls) identifying 81 genome-wide significant PTSD loci. The y axis refers to the −log10 p-value from a meta-analysis using a sample size weighted fixed-effects model. Circle colors alternate between chromosomes: even chromosomes are colored blue and odd chromosomes are colored black. The horizontal red bar indicates genome-wide significant associations (p < 5×10−8).
Extended Data Figure 3:
Extended Data Figure 3:. Significant PTSD gene-sets.
MAGMA gene-set analysis using the Molecular Signatures database (MSigDB) identifies 11 significant gene-sets. The dotted line indicates significance adjusted for the number of comparisons (p < 0.05/15,483 gene-sets). Bars depict -log10 p-values. Corresponding gene-set names are indicated to the left of bars. Terms are clustered and colored according to their Gene Ontology term category (biological processes, yellow; molecular function, blue; cellular component, red).
Extended Data Figure 4:
Extended Data Figure 4:. MAGMA tissue enrichment analysis.
MAGMA gene-property analysis in 53 specific tissue types from GTEx v8 shows enrichment of PTSD-related genes in 13 brain tissue types and in the pituitary. Bars depict -log10 p-values. Corresponding tissue names are indicated below bars. The dotted horizontal line indicates statistical significance adjusted for the number of comparisons (p < 0.05/53). Significant tissues are colored red.
Extended Data Figure 5:
Extended Data Figure 5:. MAGMA cell-type enrichment analysis in midbrain.
MAGMA gene-property analysis of 25 midbrain cell types (GSE76381) indicate enrichment of GABAergic neurons, GABAergic neuroblasts, and mediolateral neuroblasts. Vertical bars depict -log10 p-values. Significant cell types are colored blue and grey if not. The dotted horizontal line indicates statistical significance adjusted for the number of comparisons (p < 0.05/25). The asterisk (*) indicates that GABAergic neurons remained significant in stepwise conditional analysis of the other significant cell types. Abbreviations: Gaba - GABAergic neurons; NbGaba - neuroblast gabaergic; NbML1–5, mediolateral neuroblasts; DA0–2 - dopaminergicneurons; Sert, serotonergic; RN, red nucleus; Rgl 1–3, radial glia-like cells; NbM, medial neuroblast; OPC, oligodendrocyte precursor cells. ProgFPL - progenitor lateral floorplate; OMTN - oculomotor and trochlear nucleus; Endo, endothelial cells; ProgM, progenitor midline;NProg, neuronal progenitor; ProgBP, progenitorbasal plate; Mgl, microglia; ProgFPM, progenitor medial floorplate; Peric – pericytes.
Extended Data Figure 6:
Extended Data Figure 6:. PTSD genes in SynGO.
Sunburst plots show enrichment of PTSD-related genes in SynGO cellular components. The synapse is at the center ring, pre- and post-synaptic locations are at the first rings, and child terms are in subsequent outer rings. a, enrichment test results for all 415 genes mapped to PTSD GWAS loci by FUMA from one of three gene-mapping strategies (positional, expression quantitative trait loci, and chromatin interaction mapping). b, enrichment test results for 43 genes prioritized into Tier 1 using a gene prioritization strategy. Plots are colored by -log10 Q-value (see color code in the bar at left) from enrichment of PTSD genes relative to a brain expressed background set.
Extended Data Figure 7:
Extended Data Figure 7:. Genetic correlations and polygenic overlap between PTSD and other psychiatric disorders.
a, Genetic correlations (rg) between PTSD and other psychiatric disorders are indicated by circles that are drawn along the x axis. Red dots indicate SNP based heritability (h2SNP) z-score > 6 in the psychiatric disorder GWAS and colored grey to indicate z-score < 6 (rg estimates may be unreliable). The first author and publication year of source summary data is noted in parenthesis following the disorder name. b, Quantification of the polygenic overlap between PTSD and other psychiatric disorders. Euler diagrams depict Bivariate MiXeR analysis of PTSD (blue circles) and bipolar disorder (BIP), major depression (MDD), and schizophrenia (SCZ) (red circles). Values in the overlapping part of the Euler diagrams denote shared polygenicity (expressed as the number of influential variants, in thousands, with SE in parenthesis), and values in the non-overlapping part indicate dataset-specific variation. rg between dataset pairs are noted in the boxes below the Euler plots. Abbreviations: ADHD, attention deficit hyperactive disorder; alc. dep, alcohol dependence; BIP, bipolar disorder; MDD, major depression; OCD, obsessive compulsive disorder; SCZ, schizophrenia.
Figure 1 |
Figure 1 |. Data sources and analyses in PTSD Freeze 3.
a, Data sources of genome-wide association studies (GWAS) included in PGC-PTSD Freeze 3. Collections of contributing studies are pictured as bubble plots where each circle represents a contributing study. Circle areas are proportional to sample size and colors indicate the ancestry classification of participants (blue, EA; red, AA; purple, LAT). Arrowed lines indicate data sources being pooled together to perform GWAS meta-analyses stratified by ancestry. b, Methods applied for genetic characterization of PTSD, gene prioritization analyses, and translational applications. Abbreviations: EA, European ancestry, AA, African ancestry, LAT, Native American (Latin American) ancestry; EHR, electronic health record
Figure 2 |
Figure 2 |. GWAS meta-analyses in European and multi-ancestry individuals identify a total of 95 PTSD risk loci.
Overlaid Manhattan plots of European ancestry (EA; 137,136 cases and 1,085,746 controls) and multi-ancestry meta-analyses (150,760 cases and 1,130,173 controls), showing 81 genome-wide significant (GWS) loci for the EA (full circles) and 85 GWS loci for the multi-ancestry (hollow circles) analyses. Circle colors alternate between chromosomes, with even chromosomes colored blue and odd chromosomes colored black. The y-axis refers to −log10 P-values from two-sided z-tests for meta-analysis effect estimates. The horizontal red bar indicates the threshold for GWS associations (P < 5 × 10−8).
Figure 3 |
Figure 3 |. Manhattan plots of PTSD associations in multi-omic analyses.
a,b, Gene expression data from 13 brain tissue types and the pituitary were used to conduct transcriptome-wide association study (TWAS) identifying 9 loci with differential expression between PTSD cases and controls (a) and expression quantitative trait locus summary based Mendelian randomization (eQTL SMR) identifying 4 loci where gene expression has putative causal effects on PTSD (b). c, Blood protein quantitative trait locus (pQTL) SMR identify 16 blood proteins whose abundance has a putative causal effect on PTSD. The y-axis refers to −log10 P-values from two-sided z-tests for TWAS, two-sided Chi-square tests for eQTL SMR, and two-sided Chi-square tests for pQTL SMR. The horizontal red bars indicate gene-wide significance (P < 0.05/14,935 for TWAS, P < 0.05/9,903 for eQTL SMR, and P < 0.05/1,209 for pQTL SMR). Significant findings are labeled.
Figure 4 |
Figure 4 |. Gene prioritization in PTSD loci.
Summary of evidence categories of prioritized genes (Tier 1 or 2) for the top 20% of PTSD loci (as ranked by leading SNP P-value). Locus number, prioritized genes within locus, gene locations (in terms of cytogenic band), and gene tier ranks (Tier 1, orange; Tier 2, blue) are indicated on the left. Categories of evidence are grouped and colored according to the domain they belong to. CADD scores, pLI scores and fine-mapping PIPs are written within their respective squares. The total weighted scores taken across all 9 evidence categories are shown on the rightmost squares. Abbreviations: eQTL, expression QTL; CI, chromatin interaction; CADD, combined annotation dependent depletion; RDB, regulome DB; pLI, predicted loss of impact; PIP, posterior importance probability; TWAS, transcriptome-wide association study; SMR, summary Mendelian randomization; pQTL, protein QTL.
Figure 5 |
Figure 5 |. Polygenic risk score analysis for PTSD across different data sets and ancestries.
PGC-PTSD Freeze 2 and Freeze 3 European ancestry (EA) based genetic risk score (PRS) predictions into independent samples of different ancestries. The y-axis represents PTSD risk relative to the lowest quintile of PRS with 95% confidence intervals. For EA, predictions based on Freeze 3 training data (10,334 cases and 55,504 controls; blue circles) demonstrate a significant performance increase compared to predictions based on the previous Freeze 2 training GWAS (yellow circles). Based on Freeze 3 EA training data, EA individuals in the highest quintile of PRS have 2.40 (95% CI = [2.26,2.56]) fold the risk of PTSD relative to individuals in the lowest quintile PRS (blue circles). Lower prediction accuracies are found for individuals of African (AA; 10,151 cases and 22,420 controls; red circles) and Native American (LAT; 5,346 cases and 10,821 controls; purple circles) ancestries, indicating poor PRS transferability across ancestries.

References

    1. Koenen KC et al. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med 47, 2260–2274 (2017). - PMC - PubMed
    1. Davis LL et al. The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective. J Clin Psychiatry 83, 21m14116 (2022). - PubMed
    1. Ferland-Beckham C et al. Systematic review and methodological considerations for the use of single prolonged stress and fear extinction retention in rodents. Front Behav Neurosci 15, 652636 (2021). - PMC - PubMed
    1. Ressler KJ et al. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol 18, 273–288 (2022). - PMC - PubMed
    1. McClellan France J & Jovanovic T Human fear neurobiology reimagined: Can brain-derived biotypes predict fear-based disorders after trauma? Neurosci Biobehav Rev 144, 104988 (2023). - PMC - PubMed

Methods-only references

    1. Lam M et al. RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics 36, 930–933 (2020). - PMC - PubMed
    1. McCarthy S et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48, 1279–1283 (2016). - PMC - PubMed
    1. Chen CY et al. Improved ancestry inference using weights from external reference panels. Bioinformatics 29, 1399–1406 (2013). - PMC - PubMed
    1. Chang CC et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015). - PMC - PubMed
    1. Zhou X & Stephens M Genome-wide efficient mixed-model analysis for association studies. Nat Genet 44, 821–824 (2012). - PMC - PubMed

Publication types